Extended sacropelvic resection for locally recurrent rectal cancer: Can it be done safely and with good oncologic outcomes?

Dorin T. Colibaseanu, Eric Dozois, Kellie L. Mathis, Peter S. Rose, Maria L Martinez Ugarte, Zaid M. Abdelsattar, Michael D. Williams, David Larson

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

A multimodality approach to patients with locally recurrent rectal cancer that includes surgery is associated with a significant survival advantage when tumor-free margins are achieved. Patients with advanced tumors will require extended sacropelvic resection to optimize oncologic outcomes. OBJECTIVE: The aim of this study was to assess the safety, feasibility, and oncologic outcomes of extended sacropelvic resection for locally recurrent rectal cancer at our institution. DESIGN: A retrospective review identified 406 patients who had surgery for locally recurrent rectal cancer between 1997 and 2007. From this group, all patients who underwent a curative-intent sacropelvic resection were analyzed. SETTINGS: This investigation was conducted at an academic tertiary referral center. PATIENTS: Thirty patients (24 male) were identified. Median age was 59 years (range, 25-84). Operations were performed for a first local recurrence (n = 24), a second recurrence (n = 5) and for a third recurrence (n = 1). INTERVENTIONS: Twenty-six patients underwent neoadjuvant radiation, and 20 received intraoperative radiation therapy. All patients underwent extended sacropelvic resection. MAIN OUTCOME MEASURES: The primary outcomes measured were early (<30 days) and late (>30 days) surgical complications. Overall and disease-free survivals were estimated by using the Kaplan-Meier technique. RESULTS: Margin-negative resection was achieved in 93%. The most proximal level of spinal transection was the fourth lumbar space, and 4 patients underwent lower extremity amputation. There was no mortality, and early morbidity was seen in 76%. Median follow-up was 2.7 years (range, 2 months to 10.8 years). Overall survival at 2 and 5 years was 86% and 46%. Disease-free survival at 2 and 5 years was 79% and 43%. LIMITATIONS: This study was limited by its retrospective nature and the limited number of patients. CONCLUSIONS: We found extended sacropelvic resection for locally recurrent rectal cancer to be feasible and safe with overall and disease-free survival rates in comparison with survival rates seen in patients undergoing nonsacropelvic resections for locally recurrent rectal cancer.

Original languageEnglish (US)
Pages (from-to)47-55
Number of pages9
JournalDiseases of the Colon and Rectum
Volume57
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Rectal Neoplasms
Disease-Free Survival
Recurrence
Survival Rate
Survival
Amputation
Tertiary Care Centers
Lower Extremity
Radiotherapy
Radiation
Morbidity
Safety
Mortality

Keywords

  • Intraoperative radiation
  • Recurrent rectal cancer
  • Sacropelvic resection

ASJC Scopus subject areas

  • Gastroenterology
  • Medicine(all)

Cite this

Extended sacropelvic resection for locally recurrent rectal cancer : Can it be done safely and with good oncologic outcomes? / Colibaseanu, Dorin T.; Dozois, Eric; Mathis, Kellie L.; Rose, Peter S.; Ugarte, Maria L Martinez; Abdelsattar, Zaid M.; Williams, Michael D.; Larson, David.

In: Diseases of the Colon and Rectum, Vol. 57, No. 1, 01.2014, p. 47-55.

Research output: Contribution to journalArticle

Colibaseanu, Dorin T. ; Dozois, Eric ; Mathis, Kellie L. ; Rose, Peter S. ; Ugarte, Maria L Martinez ; Abdelsattar, Zaid M. ; Williams, Michael D. ; Larson, David. / Extended sacropelvic resection for locally recurrent rectal cancer : Can it be done safely and with good oncologic outcomes?. In: Diseases of the Colon and Rectum. 2014 ; Vol. 57, No. 1. pp. 47-55.
@article{d365265316304e47bd1eeb5482a0e18e,
title = "Extended sacropelvic resection for locally recurrent rectal cancer: Can it be done safely and with good oncologic outcomes?",
abstract = "A multimodality approach to patients with locally recurrent rectal cancer that includes surgery is associated with a significant survival advantage when tumor-free margins are achieved. Patients with advanced tumors will require extended sacropelvic resection to optimize oncologic outcomes. OBJECTIVE: The aim of this study was to assess the safety, feasibility, and oncologic outcomes of extended sacropelvic resection for locally recurrent rectal cancer at our institution. DESIGN: A retrospective review identified 406 patients who had surgery for locally recurrent rectal cancer between 1997 and 2007. From this group, all patients who underwent a curative-intent sacropelvic resection were analyzed. SETTINGS: This investigation was conducted at an academic tertiary referral center. PATIENTS: Thirty patients (24 male) were identified. Median age was 59 years (range, 25-84). Operations were performed for a first local recurrence (n = 24), a second recurrence (n = 5) and for a third recurrence (n = 1). INTERVENTIONS: Twenty-six patients underwent neoadjuvant radiation, and 20 received intraoperative radiation therapy. All patients underwent extended sacropelvic resection. MAIN OUTCOME MEASURES: The primary outcomes measured were early (<30 days) and late (>30 days) surgical complications. Overall and disease-free survivals were estimated by using the Kaplan-Meier technique. RESULTS: Margin-negative resection was achieved in 93{\%}. The most proximal level of spinal transection was the fourth lumbar space, and 4 patients underwent lower extremity amputation. There was no mortality, and early morbidity was seen in 76{\%}. Median follow-up was 2.7 years (range, 2 months to 10.8 years). Overall survival at 2 and 5 years was 86{\%} and 46{\%}. Disease-free survival at 2 and 5 years was 79{\%} and 43{\%}. LIMITATIONS: This study was limited by its retrospective nature and the limited number of patients. CONCLUSIONS: We found extended sacropelvic resection for locally recurrent rectal cancer to be feasible and safe with overall and disease-free survival rates in comparison with survival rates seen in patients undergoing nonsacropelvic resections for locally recurrent rectal cancer.",
keywords = "Intraoperative radiation, Recurrent rectal cancer, Sacropelvic resection",
author = "Colibaseanu, {Dorin T.} and Eric Dozois and Mathis, {Kellie L.} and Rose, {Peter S.} and Ugarte, {Maria L Martinez} and Abdelsattar, {Zaid M.} and Williams, {Michael D.} and David Larson",
year = "2014",
month = "1",
doi = "10.1097/DCR.0000000000000015",
language = "English (US)",
volume = "57",
pages = "47--55",
journal = "Diseases of the Colon and Rectum",
issn = "0012-3706",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Extended sacropelvic resection for locally recurrent rectal cancer

T2 - Can it be done safely and with good oncologic outcomes?

AU - Colibaseanu, Dorin T.

AU - Dozois, Eric

AU - Mathis, Kellie L.

AU - Rose, Peter S.

AU - Ugarte, Maria L Martinez

AU - Abdelsattar, Zaid M.

AU - Williams, Michael D.

AU - Larson, David

PY - 2014/1

Y1 - 2014/1

N2 - A multimodality approach to patients with locally recurrent rectal cancer that includes surgery is associated with a significant survival advantage when tumor-free margins are achieved. Patients with advanced tumors will require extended sacropelvic resection to optimize oncologic outcomes. OBJECTIVE: The aim of this study was to assess the safety, feasibility, and oncologic outcomes of extended sacropelvic resection for locally recurrent rectal cancer at our institution. DESIGN: A retrospective review identified 406 patients who had surgery for locally recurrent rectal cancer between 1997 and 2007. From this group, all patients who underwent a curative-intent sacropelvic resection were analyzed. SETTINGS: This investigation was conducted at an academic tertiary referral center. PATIENTS: Thirty patients (24 male) were identified. Median age was 59 years (range, 25-84). Operations were performed for a first local recurrence (n = 24), a second recurrence (n = 5) and for a third recurrence (n = 1). INTERVENTIONS: Twenty-six patients underwent neoadjuvant radiation, and 20 received intraoperative radiation therapy. All patients underwent extended sacropelvic resection. MAIN OUTCOME MEASURES: The primary outcomes measured were early (<30 days) and late (>30 days) surgical complications. Overall and disease-free survivals were estimated by using the Kaplan-Meier technique. RESULTS: Margin-negative resection was achieved in 93%. The most proximal level of spinal transection was the fourth lumbar space, and 4 patients underwent lower extremity amputation. There was no mortality, and early morbidity was seen in 76%. Median follow-up was 2.7 years (range, 2 months to 10.8 years). Overall survival at 2 and 5 years was 86% and 46%. Disease-free survival at 2 and 5 years was 79% and 43%. LIMITATIONS: This study was limited by its retrospective nature and the limited number of patients. CONCLUSIONS: We found extended sacropelvic resection for locally recurrent rectal cancer to be feasible and safe with overall and disease-free survival rates in comparison with survival rates seen in patients undergoing nonsacropelvic resections for locally recurrent rectal cancer.

AB - A multimodality approach to patients with locally recurrent rectal cancer that includes surgery is associated with a significant survival advantage when tumor-free margins are achieved. Patients with advanced tumors will require extended sacropelvic resection to optimize oncologic outcomes. OBJECTIVE: The aim of this study was to assess the safety, feasibility, and oncologic outcomes of extended sacropelvic resection for locally recurrent rectal cancer at our institution. DESIGN: A retrospective review identified 406 patients who had surgery for locally recurrent rectal cancer between 1997 and 2007. From this group, all patients who underwent a curative-intent sacropelvic resection were analyzed. SETTINGS: This investigation was conducted at an academic tertiary referral center. PATIENTS: Thirty patients (24 male) were identified. Median age was 59 years (range, 25-84). Operations were performed for a first local recurrence (n = 24), a second recurrence (n = 5) and for a third recurrence (n = 1). INTERVENTIONS: Twenty-six patients underwent neoadjuvant radiation, and 20 received intraoperative radiation therapy. All patients underwent extended sacropelvic resection. MAIN OUTCOME MEASURES: The primary outcomes measured were early (<30 days) and late (>30 days) surgical complications. Overall and disease-free survivals were estimated by using the Kaplan-Meier technique. RESULTS: Margin-negative resection was achieved in 93%. The most proximal level of spinal transection was the fourth lumbar space, and 4 patients underwent lower extremity amputation. There was no mortality, and early morbidity was seen in 76%. Median follow-up was 2.7 years (range, 2 months to 10.8 years). Overall survival at 2 and 5 years was 86% and 46%. Disease-free survival at 2 and 5 years was 79% and 43%. LIMITATIONS: This study was limited by its retrospective nature and the limited number of patients. CONCLUSIONS: We found extended sacropelvic resection for locally recurrent rectal cancer to be feasible and safe with overall and disease-free survival rates in comparison with survival rates seen in patients undergoing nonsacropelvic resections for locally recurrent rectal cancer.

KW - Intraoperative radiation

KW - Recurrent rectal cancer

KW - Sacropelvic resection

UR - http://www.scopus.com/inward/record.url?scp=84893462303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893462303&partnerID=8YFLogxK

U2 - 10.1097/DCR.0000000000000015

DO - 10.1097/DCR.0000000000000015

M3 - Article

C2 - 24316945

AN - SCOPUS:84893462303

VL - 57

SP - 47

EP - 55

JO - Diseases of the Colon and Rectum

JF - Diseases of the Colon and Rectum

SN - 0012-3706

IS - 1

ER -